Articles From: Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury to AstraZeneca slides; Adidas jumps: Europe's big stock movers


Provides for Immediate Release of Initial Grant Funds MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury investment picks
- Welcomes New Shareholders Who Received Series A Shares from Geron Corporation - MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution investment picks
Dose Escalation Clinical Trial to Test Initial Safety and Activity of AST-OPC1 in Patient Population with the First Indication Targeted for Product Registration FDA Clearance Triggers Definitive Contract Finalization with California Institute of Regenerative Medicine (CIRM) to Begin $14.3 Million in Trial Funding MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury investment picks
2014/11/10
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Reports Third Quarter Financial and Operating Results investment picks
Trading on NYSE MKT Expected to Begin on October 8, 2014 under Ticker Symbol AST MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT investment picks
2014/10/31
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics to Report Third Quarter Results on November 10, 2014 investment picks
Aston Hill Announces 2014 Third Quarter Results Canada NewsWire CALGARY , Nov.
Sign-up for Aston Hill Announces 2014 Third Quarter Results investment picks
2014/10/15
Aston Hill announces renewal of normal course issuer bid Canada NewsWire CALGARY , Oct.
Sign-up for Aston Hill announces renewal of normal course issuer bid investment picks
2014/10/22
Aston Hill Asset Management Inc. Declares Distributions Canada NewsWire TORONTO , Oct.
Sign-up for Aston Hill Asset Management Inc. Declares Distributions investment picks
2014/10/22
Aston Hill Capital Markets Inc. Declares Distributions Canada NewsWire TORONTO , Oct.
Sign-up for Aston Hill Capital Markets Inc. Declares Distributions investment picks
2014/9/19
Aston Hill Capital Markets Inc. declares distributions Canada NewsWire TORONTO , Sept.
Sign-up for Aston Hill Capital Markets Inc. declares distributions investment picks
Aston Hill Financial Announces Quarterly Cash Dividend Canada NewsWire CALGARY , Nov.
Sign-up for Aston Hill Financial Announces Quarterly Cash Dividend investment picks
Aston Hill Reports Third Quarter Assets Under Management Canada NewsWire CALGARY , Oct.
Sign-up for Aston Hill Reports Third Quarter Assets Under Management investment picks
Aston Hotels & Resorts, an operating business of Interval Leisure Group (Nasdaq:IILG), announced that it has entered into property management agreements with Split Rock Resort & Golf Club and The Mountain Laurel Resort & Spa situated in the scenic Pocono Mountains region of Lake Harmony, Pennsylvania.
Sign-up for Aston Hotels & Resorts Assumes Management of Split Rock Resort & Golf Club and Mountain Laurel Resort & Spa investment picks
2014/10/7
LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Bank and Long Island Girl Scouts Distribute School Supplies to Local Children investment picks
2014/10/9
LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Bank Unveils Plans For Melville Branch investment picks
2014/10/15
Quarterly Cash Dividend of $0.04 Per Common Share Declared LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Financial Corporation Reports Third Quarter Earnings Per Common Share Of $0.17 investment picks
2014/10/1
LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Financial Corporation Schedules Third Quarter 2014 Earnings Release & Conference Call investment picks
2014/8/22
LAKE SUCCESS, N.Y. , Aug.
Sign-up for Astoria Financial Corporation To Present At Barclays Global Financial Services Conference investment picks
2014/10/30
By I Made Sentana JAKARTA, Indonesia--PT Astra International (ASII.JK) booked a net profit of 4.7 trillion rupiah ($388.2 million) in the July-September period, unchanged from a year earlier.
Sign-up for Astra International 3Q Net Profit IDR4.7 Trillion Vs IDR4.7 Trillion investment picks
FRANKFURT--The following is a summary of analysts' forecasts for AstraZeneca plc (AZN) third-quarter results, based on a poll of nine analysts conducted by Dow Jones Newswires (figures in million dollars, EPS in dollar, target price in pence, according to IFRS). Earnings figures are scheduled to be released November 6.
Sign-up for AstraZeneca 3Q 2014 -- Forecast investment picks
LONDON and SUNNYVALE, Calif.
Sign-up for AstraZeneca And Pharmacyclics Enter Clinical Trial Collaboration To Evaluate IMBRUVICA® In Hematologic Cancers investment picks
LONDON and SUNNYVALE, Calif.
Sign-up for AstraZeneca And Pharmacyclics Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors investment picks
2014/10/30
LONDON--British-Swedish drugmaker AstraZeneca PLC (AZN.LN) said Thursday it received approval from the U.S. Food and Drug Administration for Xigduo XR as a daily treatment for type 2 diabetes.
Sign-up for AstraZeneca Approved For Diabetes Treatment investment picks
2014/10/30
By Ed Ballard LONDON--British-Swedish drugmaker AstraZeneca PLC (AZN.LN) said Thursday it received approval from the U.S. Food and Drug Administration for Xigduo XR as a daily treatment for type 2 diabetes.
Sign-up for AstraZeneca Gets U.S. Approval For Xigduo XR Diabetes Treatment investment picks
2014/10/15
Recognizing that each person with type 2 diabetes is unique, AstraZeneca today announced the launch of Fit2Me , a free diet and lifestyle support program that allows people with this complex disease to create a diabetes care plan that is custom fit to their likes and dislikes.
Sign-up for AstraZeneca Launches Fit2Me™, a Free Customized Diet and Lifestyle Support Program for People with Type 2 Diabetes investment picks
2014/11/6
LONDON--Pharmaceutical company AstraZeneca PLC (AZN.LN) raised its earnings guidance for the year Thursday, as it continues to benefit from the delayed launch of a rival's copy of one of its best-selling drugs, but its profits slid as it continues to invest in marketing efforts and new drug development.
Sign-up for AstraZeneca Raises Earning Guidance for 2014 investment picks
2014/11/6
By Hester Plumridge LONDON--Pharmaceutical company AstraZeneca PLC (AZN.LN) raised its earnings guidance for the year Thursday, as it continues to benefit from the delayed launch of a rival's copy of one of its best-selling drugs, but its profits slid as it continues to invest in marketing efforts and new drug development.
Sign-up for AstraZeneca Raises Earning Guidance for 2014 Despite Slide in Profits investment picks
2014/11/6
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Here are some companies whose shares are making notable moves in European trade on Thursday.
Sign-up for AstraZeneca slides; Adidas jumps: Europe's big stock movers investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury to AstraZeneca slides; Adidas jumps: Europe's big stock movers
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent